reviewCritical Reviews in ToxicologyJan 1, 2004Closed access

The Toxicology of Perfluorooctanoate

DuPont (United States) · Delaware Technical Community College · +3 more institutions

Indexed incrossref

Abstract

PFOA is a peroxisome proliferator (PPAR agonist) and exerts morphological and biochemical effects characteristic of PPAR agonists. These effects include increased β-oxidation of fatty acids, increases in several cytochrome P-450 (CYP450)-mediated reactions, and inhibition of the secretion of very low-density lipoproteins and cholesterol from the liver. These effects on lipid metabolism and transport result in a reduction of cholesterol and triglycerides in serum and an accumulation of lipids in the liver. The triad of tumors observed (liver, Leydig cell, and pancreatic acinar-cell) is typical of many PPAR agonists and is believed to involve nongenotoxic mechanisms. The hepatocellular tumors observed in rats…

Citation impact

739
total citations
FWCI
11.93
Percentile
100%
References
136
Citations per year

Authors

9

Topics & keywords

Keywords
  • Endocrinology
  • Internal medicine
  • Leydig cell
  • Peroxisome
  • Peroxisome proliferator
  • Peroxisome proliferator-activated receptor
  • Pancreas
  • Mechanism (biology)
UN Sustainable Development Goals
  • Good health and well-being
No related works found for this paper.